This company has been acquired
Abliva Management
Management criteria checks 3/4
Abliva's CEO is Ellen Donnelly, appointed in Feb 2021, has a tenure of 4.08 years. total yearly compensation is SEK7.03M, comprised of 54.1% salary and 45.9% bonuses, including company stock and options. directly owns 0.023% of the company’s shares, worth $16.45K. The average tenure of the management team and the board of directors is 9.2 years and 8.2 years respectively.
Key information
Ellen Donnelly
Chief executive officer
SEK 7.0m
Total compensation
| CEO salary percentage | 54.09% |
| CEO tenure | 4.1yrs |
| CEO ownership | 0.02% |
| Management average tenure | 9.2yrs |
| Board average tenure | 8.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | n/a | n/a | -SEK 90m |
| Sep 30 2024 | n/a | n/a | -SEK 89m |
| Jun 30 2024 | n/a | n/a | -SEK 102m |
| Mar 31 2024 | n/a | n/a | -SEK 98m |
| Dec 31 2023 | SEK 7m | SEK 4m | -SEK 96m |
| Sep 30 2023 | n/a | n/a | -SEK 88m |
| Jun 30 2023 | n/a | n/a | -SEK 80m |
| Mar 31 2023 | n/a | n/a | -SEK 79m |
| Dec 31 2022 | SEK 6m | SEK 3m | -SEK 85m |
| Sep 30 2022 | n/a | n/a | -SEK 105m |
| Jun 30 2022 | n/a | n/a | -SEK 114m |
| Mar 31 2022 | n/a | n/a | -SEK 124m |
| Dec 31 2021 | SEK 4m | SEK 2m | -SEK 123m |
Compensation vs Market: Ellen's total compensation ($USD695.08K) is about average for companies of similar size in the US market ($USD643.82K).
Compensation vs Earnings: Ellen's compensation has increased whilst the company is unprofitable.
CEO
Ellen Donnelly (50 yo)
Dr. Ellen K. Donnelly, Ph D has been Chief Executive Officer at Abliva AB (publ) since February 03, 2021. She serves as Independent Director at Modus Therapeutics Holding Ab since 2020.Dr. Donnelly had be...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 4.1yrs | SEK 7.03m | 0.023% $ 16.4k | |
| Deputy CEO | 11.3yrs | no data | 0.020% $ 13.8k | |
| Chief Scientific Officer & VP of Discovery | 25.2yrs | SEK 247.00k | 0.046% $ 32.3k | |
| Communications Officer & Lab Manager | no data | no data | no data | |
| Chief Medical Officer and VP of Preclinical & Clinical Development | 9.2yrs | no data | 0.053% $ 37.4k | |
| Vice President of Clinical Operations | 2.1yrs | no data | 0.0013% $ 948.3 | |
| Consultant | no data | no data | no data |
Experienced Management: NEVP.F's management team is seasoned and experienced (9.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Chairman of the Board | 8.9yrs | SEK 1.43m | 0.14% $ 100.8k | |
| Independent Director | 8.2yrs | SEK 477.00k | 0.0085% $ 6.0k | |
| Independent Director | 8.2yrs | SEK 438.00k | 0.0039% $ 2.7k | |
| Independent Director | 6.9yrs | SEK 464.00k | no data | |
| Independent Director | 4.7yrs | no data | 14.71% $ 10.4m |
Experienced Board: NEVP.F's board of directors are considered experienced (8.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/18 06:25 |
| End of Day Share Price | 2025/01/23 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Abliva AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Patrik Ling | DNB Carnegie |
| Jonas Peciulis | Edison Investment Research |
| Niklas Elmhammer | Redeye |